INFLAMMATION AND MULTISTAGE CARCINOGENESIS

炎症和多期致癌

基本信息

  • 批准号:
    2733319
  • 负责人:
  • 金额:
    $ 28.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-09-01 至 2001-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: Although there are circumstantial links between inflammation and squamous cell carcinoma growth, there have been no studies that have directly examined the critical role of activated leukocytes and pro-inflammatory cytokines to skin multistage carcinogenesis. The hypothesis for the proposed studies is that leukocytes and cytokines produced by leukocytes and epidermal keratinocytes are essential to the growth of skin papillomas induced in transgenic TG.AC mice that contain an activated v-Ha-ras by 5 topical treatments with 2 yg TPA or by exposure to 100 nmol 7,12 DMBA. The importance of leukocytes and pro-inflammatory cytokines to malignant conversion of papillomas to carcinomas will be assessed in Sencar mice treated with a single 20 yg dose of DMBA followed by 5 treatments with 2 yg TPA which induces papillomas with a high rate of malignant conversion. Selective inhibition of dermal leukocyte infiltration or inhibition of synthesis of pro-inflammatory cytokines will effectively inhibit (a) the formation of DNA lesions that are sensitive to formamido-N-glycosylase (FaPY), Endonuclease III and IV: (b) proliferation of keratinocyte subpopulations within the epidermis and follicular regions; (c) growth of papillomas and (d) the rate of conversion of papillomas to carcinomas. To examine this hypothesis, the following Specific Aims are proposed: 1) Examine the ability of the cytokine synthesis inhibitor Pentoxifylline to inhibit infiltration of leukocyte populations, inhibit cytokine gene expression, inhibit DNA damage and oxidative 8-oxo-dG adduct formation in TG.AC v-Ha-ras transgenic mice during papilloma growth induced by either 100 nmol DMBA or 2 yg TPA; 2) Examine the effect of i.v. injection of TG.AC v-Ha-ras transgenic mice with anti-B2 integrin antibodies on tumor promotion; 3) Determine the extent to which inflammation contributes to conversion of papillomas to carcinomas by examining the effect of administration of either Pentoxifylline or anti-B2 integrin antibodies on cyclin D1 overexpression and the timing of development of mutations within exons 5-8 of the p53 tumor suppressor gene which is mutated at high frequency during malignant conversion. These studies provide the unique opportunity to determine the direct link between inflammation, promotion and malignant conversion.
描述:虽然炎症与炎症之间存在间接联系, 和鳞状细胞癌的生长,还没有研究表明 直接研究了活化白细胞的关键作用, 促炎细胞因子对皮肤多阶段癌变的影响。 的 提出的研究假设是白细胞和细胞因子 由白细胞和表皮角质形成细胞产生的是必不可少的 在转基因TG.AC小鼠中诱导的皮肤乳头状瘤的生长, 用2 μ g TPA局部处理5次或暴露于 100 nmol 7.12 DMBA。 白细胞和促炎因子的重要性 细胞因子对乳头状瘤向癌的恶性转化的作用将是 在用单次20 μ g剂量的DMBA处理的Sencar小鼠中评估, 用2 μ g TPA进行5次治疗,诱导乳头状瘤, 恶性转化 选择性抑制真皮白细胞浸润 或抑制促炎细胞因子的合成将有效地 抑制(a)对以下物质敏感的DNA损伤的形成 甲酰胺基-N-糖基化酶(FaPY),核酸内切酶III和IV:(B)增殖 表皮和毛囊区域内的角质形成细胞亚群; (c)乳头状瘤的生长和(d)乳头状瘤转化为 癌 为了检验这一假设,以下具体目标是 建议:1)检查细胞因子合成抑制剂的能力 喷替福林抑制白细胞群浸润,抑制 细胞因子基因表达,抑制DNA损伤和氧化8-oxo-dG加合物 TG.AC v-Ha-ras转基因小鼠在乳头状瘤生长诱导过程中形成 用100 nmol DMBA或2 μ g TPA分别对小鼠进行了免疫组化检测; 2)检测静脉注射DMBA或TPA的效果 抗B2整合素抗体对TG.AC v-Ha-ras转基因小鼠肿瘤生长的影响 3)确定炎症在多大程度上有助于促进 乳头状瘤向癌的转化, 施用喷替福林或抗B2整联蛋白抗体, 细胞周期蛋白D1的过度表达和细胞内突变的发生时间 p53肿瘤抑制基因的外显子5-8,其在高水平突变, 恶性转化的频率。 这些研究提供了独特的 有机会确定炎症、促进和 恶性转化

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FREDIKA A ROBERTSON其他文献

FREDIKA A ROBERTSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FREDIKA A ROBERTSON', 18)}}的其他基金

NITRIC OXIDE AND TUMOR PROMOTION
一氧化氮与肿瘤促进
  • 批准号:
    2462954
  • 财政年份:
    1997
  • 资助金额:
    $ 28.09万
  • 项目类别:
GENE SPECIFIC MUTATIONS IN SKIN INDUCED BY PEROXYNITRITE
过氧亚硝酸盐引起的皮肤基因特异性突变
  • 批准号:
    6172945
  • 财政年份:
    1997
  • 资助金额:
    $ 28.09万
  • 项目类别:
GENE SPECIFIC MUTATIONS IN SKIN INDUCED BY PEROXYNITRITE
过氧亚硝酸盐引起的皮肤基因特异性突变
  • 批准号:
    6376215
  • 财政年份:
    1997
  • 资助金额:
    $ 28.09万
  • 项目类别:
NITRIC OXIDE AND TUMOR PROMOTION
一氧化氮与肿瘤促进
  • 批准号:
    2837792
  • 财政年份:
    1997
  • 资助金额:
    $ 28.09万
  • 项目类别:
GENE SPECIFIC MUTATIONS IN SKIN INDUCED BY PEROXYNITRITE
过氧亚硝酸盐引起的皮肤基因特异性突变
  • 批准号:
    2683636
  • 财政年份:
    1997
  • 资助金额:
    $ 28.09万
  • 项目类别:
NITRIC OXIDE AND TUMOR PROMOTION
一氧化氮与肿瘤促进
  • 批准号:
    6124460
  • 财政年份:
    1997
  • 资助金额:
    $ 28.09万
  • 项目类别:
INFLAMMATION AND MULTISTAGE CARCINOGENESIS
炎症和多期致癌
  • 批准号:
    6172864
  • 财政年份:
    1997
  • 资助金额:
    $ 28.09万
  • 项目类别:
INFLAMMATION AND MULTISTAGE CARCINOGENESIS
炎症和多期致癌
  • 批准号:
    2405128
  • 财政年份:
    1997
  • 资助金额:
    $ 28.09万
  • 项目类别:
INFLAMMATION AND MULTISTAGE CARCINOGENESIS
炎症和多期致癌
  • 批准号:
    2895808
  • 财政年份:
    1997
  • 资助金额:
    $ 28.09万
  • 项目类别:
GENE SPECIFIC MUTATIONS IN SKIN INDUCED BY PEROXYNITRITE
过氧亚硝酸盐引起的皮肤基因特异性突变
  • 批准号:
    2895481
  • 财政年份:
    1997
  • 资助金额:
    $ 28.09万
  • 项目类别:

相似海外基金

Development of an HPV stigma assessment scale and a stigma-reducing intervention to improve cervical cancer prevention in El Salvador
制定 HPV 耻辱评估量表和减少耻辱干预措施,以改善萨尔瓦多的宫颈癌预防
  • 批准号:
    10844859
  • 财政年份:
    2023
  • 资助金额:
    $ 28.09万
  • 项目类别:
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
  • 批准号:
    10829054
  • 财政年份:
    2023
  • 资助金额:
    $ 28.09万
  • 项目类别:
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
KEMRI-PHRD UG1 级联网络单元:艾滋病毒感染女性的宫颈癌预防研究
  • 批准号:
    10763054
  • 财政年份:
    2023
  • 资助金额:
    $ 28.09万
  • 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
  • 批准号:
    10758129
  • 财政年份:
    2023
  • 资助金额:
    $ 28.09万
  • 项目类别:
TOPIC 453: THE PERFECT MEDICAL ASSISTANT FOR CANCER PREVENTION WITHIN PRIMARY CARE
主题 453:初级保健中预防癌症的完美医疗助手
  • 批准号:
    10931123
  • 财政年份:
    2023
  • 资助金额:
    $ 28.09万
  • 项目类别:
Co-creating a community engagement knowledge translation summit on improving cancer prevention and screening in Canada
共同创建社区参与知识翻译峰会,以改善加拿大的癌症预防和筛查
  • 批准号:
    480839
  • 财政年份:
    2023
  • 资助金额:
    $ 28.09万
  • 项目类别:
    Miscellaneous Programs
PIECES – Towards Large-Scale Adaption and Tailored Implementation of Evidence-Based Primary Cancer Prevention Programmes in Europe and Beyond
部分内容 — 致力于在欧洲及其他地区大规模适应和定制实施循证初级癌症预防计划
  • 批准号:
    10079747
  • 财政年份:
    2023
  • 资助金额:
    $ 28.09万
  • 项目类别:
    EU-Funded
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
  • 批准号:
    10737017
  • 财政年份:
    2023
  • 资助金额:
    $ 28.09万
  • 项目类别:
A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda
乌干达宫颈癌预防游戏规则改变者的混合实施-有效性试验
  • 批准号:
    10718609
  • 财政年份:
    2023
  • 资助金额:
    $ 28.09万
  • 项目类别:
Using mHealth to investigate intersectionality and health behaviors: Implications for conceptual models and cancer prevention interventions for marginalized populations
使用移动医疗研究交叉性和健康行为:对边缘化人群的概念模型和癌症预防干预措施的影响
  • 批准号:
    10746886
  • 财政年份:
    2023
  • 资助金额:
    $ 28.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了